Confession: I have a desk drawer filled with gel pens in a variety of colors (think neon pink, shimmery gold, deep black and beyond). I use them to write birthday cards for my friends and for my ...

Osteoarthritis affects around 600 million people globally. It causes pain, stiffness and reduced joint function – most commonly in the knees, hands and hips. There’s currently no cure for ...

Knee osteoarthritis is a complex disease that affects the whole joint, including bone, cartilage, ligaments and muscles. Osteoarthritis is a common cause of pain and movement difficulty, affecting 8.3 ...

If you’ve checked social media today, you may have stumbled across a see-through ballpoint pen with real parasites swimming around inside it (and maybe dismissed it as AI slop). Prompting grossed-out ...

Nestled in Trump’s budget proposal are suggestions for onshoring U.S. drug manufacturing. FDA Commissioner Marty Makary cited the need to counter China’s dominance in early stage drug development, ...

Two more drug-making giants will officially start selling popular commercial medications on the White House's discounted pharmaceutical site as soon as Monday, CBS News exclusively learned. American ...

Please provide your email address to receive an email when new articles are posted on . Adalimumab biosimilar prescriptions increased nearly 25% after CVS added them to the formulary. However, some of ...

If you could inject yourself with a substance that purports to make you tanner, fitter and healthier, would you? Many people are saying “yes.” Online, social media influencers tout vials of substances ...

A demo for Tomodachi Life: Living the Dream, dubbed the “Welcome Version,” is now available for Switch via Nintendo eShop, Nintendo announced. Save data from the demo can be transferred to the full ...

While GLP-1 weight loss meds have been a mainstay in pop culture for a few years now, they're potentially about to get even more widespread. Formerly only available as an injection, Wegovy recently ...

A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered a more powerful CD40 agonist antibody and changed how ...